InterCure Ltd. (NASDAQ:INCR – Get Free Report) was the target of a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 17,800 shares, a drop of 12.7% from the September 30th total of 20,400 shares. Based on an average daily volume of 24,800 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.1% of the company’s stock are short sold.
Institutional Investors Weigh In On InterCure
A number of institutional investors and hedge funds have recently made changes to their positions in INCR. Renaissance Technologies LLC boosted its stake in InterCure by 30.9% during the 2nd quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after purchasing an additional 10,700 shares during the last quarter. AdvisorShares Investments LLC purchased a new position in shares of InterCure during the second quarter valued at approximately $218,000. Finally, Tidal Investments LLC bought a new stake in InterCure during the first quarter worth $883,000. Institutional investors and hedge funds own 8.34% of the company’s stock.
InterCure Stock Up 0.6 %
INCR stock traded up $0.01 during midday trading on Tuesday, reaching $1.74. 22,442 shares of the company’s stock traded hands, compared to its average volume of 53,892. InterCure has a 52 week low of $0.99 and a 52 week high of $3.72. The company has a market cap of $79.30 million, a price-to-earnings ratio of 13.31 and a beta of 1.50. The firm’s fifty day moving average price is $1.92 and its 200-day moving average price is $2.31. The company has a quick ratio of 1.15, a current ratio of 1.78 and a debt-to-equity ratio of 0.15.
About InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Featured Stories
- Five stocks we like better than InterCure
- What is the FTSE 100 index?
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What is the S&P 500 and How It is Distinct from Other Indexes
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Financial Services Stocks Investing
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.
